System and method for pharmaceutical item and prescription management

• US 20060235726A1
• Filed: 04/18/2005
• Published: 10/19/2006
• Est. Priority Date: 04/18/2005
• Status: Abandoned Application

• Current Assignee: Lotmax Paraison, Ronald Backer
• Original Assignee: Lotmax Paraison, Ronald Backer
• Inventors: Paraison, Lotmax, Backer, Ronald
• Application Number:
  US11/108,315
• Publication Number:
  US 20060235726A1
• Time in Patent Office: Days
• US Class Current: 705/2
• CPC Class Codes: G06Q 10/10 Office automation; Time management
• CPC Class Codes: G06Q 40/08 Insurance
• CPC Class Codes: G16H 10/60 for patient-specific data, e.g. for electronic patient records
• CPC Class Codes: G16H 20/10 relating to drugs or medications, e.g. for ensuring correct administration to patients

Abstract

A system for managing information about pharmaceuticals, patients and health care providers.

Claims

1. A system for managing information about pharmaceuticals, patients, and health care providers, comprising

a database for storing pharmaceutical data and patient data;

a communications device capable of reading identifiers, displaying data, and receiving electronic signatures;

a communications pathway;

a management system capable of communicating with the communications device over the communications pathway and with the database, the management system supplying an identifier to be used on a readable label attached to an item such that the identifier can be read by the communications device.

2. The system of claim 1, wherein the item further comprises a pharmaceutical item being transferred from a first entity to a second entity wherein the communications device is capable of receiving a signature of the second entity indicative of the transfer.

3. The system of claim 1, wherein the item further comprises a patient chart containing information about a patient.

4. The system of claim 2, wherein the first entity further comprises a pharmaceutical manufacturer and the second entity further comprises a pharmaceutical representative.

5. The system of claim 2, wherein the first entity further comprises a pharmaceutical representative and the second entity further comprises a health care provider.

6. The system of claim 2, wherein the first entity further comprises a health care provider and the second entity further comprises a patient.

7. The system of claim 2, wherein the pharmaceutical item further comprises a pharmaceutical sample.

8. The system of claim 2, wherein the pharmaceutical item further comprises an injectable item.

9. The system of claim 1, wherein the readable label further comprises a barcode label containing the system supplied identifier in barcode form.

10. The system of claim 1, wherein the readable label further comprises a radio frequency label containing the system supplied identifier in radio frequency form.

11. The system of claim 1, wherein the communications device is a personal digital assistant.

12. The system of claim 1, wherein the communications device is a personal computer.

13. The system of claim 1, wherein the communications device is a cellular telephone.

14. The system of claim 2, wherein the electronic signature further comprises an electronic signature created by use of a stylus.

15. The system of claim 2, wherein the electronic signature further comprises an electronic signature created by use of a wireless technology pen.

16. The system of claim 3, wherein the patient data further comprises diagnostic, clinical, and treatment data about the patient.

17. The system of claim 2, wherein the management system further comprises a chain of custody program for logging any transfers of the pharmaceutical item.

18. The system of claim 2, wherein the management system further comprises an inventory program for keeping track of the pharmaceutical item and providing a replenishment indicator.

19. The system of claim 6 wherein the management system further comprises a formulary checking program for determining whether a proposed pharmaceutical is covered by the patient'"'"'s medical insurer.

20. The system of claim 6, wherein the management system further comprises an informed consent program which identifies any drug interaction and instruction information relevant to a proposed prescription, provides the information in readable form to the patient, and stores the patient'"'"'s electronic signature confirming receipt of same.

21. The system of claim 20, wherein the management system further comprises an electronic prescription writer which automatically generates a prescription upon authorization by the health care provider and transmits it.

22. The system of claim 6, wherein the management system further comprises a primary diagnosis indicator for displaying at least one primary diagnosis for a patient whenever that patient'"'"'s information is being viewed by the health care provider.

23. The system of claim 1, wherein the management system further comprises a transaction logging function to permanently record and identify designated transactions.

24. The system of claim 16, wherein the management system further comprises a patient record program that associates the identifier from the patient'"'"'s chart with stored patient data in the database.

25. The system of claim 24, wherein the management system further comprises an adherence data gatherer which collects and displays clinical information about the patient stored in the database, the information being indicative of the patient'"'"'s compliance with a prescribed treatment.

26. The system of claim 24, wherein the management system further comprises a network analysis program for analyzing reactions of a specified group of patients stored in the database to prescribed treatments and reporting the results without divulging any patient identifying data.

27. The system of claim 24, wherein the management information system further comprises a clinical response analyzer which compares patient data stored in the database to standard response data stored in the database for prescribed treatments to determine whether the patient is responding as expected.

28. The system of claim 24, wherein the management information system further comprises an outcomes analyzer for comparing patient data for patients having the same diagnosis but at least two different prescribed treatments and summarizing the outcomes.

29. A method for managing information about pharmaceuticals, patients, and health care providers, comprising the steps of:

storing pharmaceutical data and patient data in a database;

communicating with a communications device capable of reading identifiers, displaying data, and receiving electronic signatures;

signaling over a communications pathway;

managing information through a management system capable of communicating with the communications device of the communications pathway and with the management system supplying an identifier for an item to be used on a readable label attached to the item such that the identifier can be read by the communications device.

30. The method of claim 29, wherein the step of supplying an identifier for an item further comprises the step of supplying an identifier for a pharmaceutical item being transferred from a first entity to a second entity so that a signature of the second entity can be received by the communications device when the second entity acknowledges the transfer.

31. The method of claim 29, wherein the step of supplying an identifier for an item further comprises the step of supplying an identifier for a patient chart.

32. The method of claim 30, wherein the step of supplying an identifier for a pharmaceutical item being transferred from a first entity to a second entity further comprises the step of recognizing the first entity as a pharmaceutical manufacturer and the second entity as a pharmaceutical representative.

33. The method of claim 30, wherein the step of supplying an identifier for a pharmaceutical item being transferred from a first entity to a second entity further comprises the step of recognizing the first entity as a pharmaceutical representative and the second entity as a health care provider.

34. The method of claim 30, wherein the step of supplying an identifier for a pharmaceutical item being transferred from a first entity to a second entity further comprises the step of recognizing the first entity as a health care provider and the second entity as a patient.

35. The method of claim 30, wherein the step of supplying an identifier for pharmaceutical item further comprises the step of supplying an identifier for a pharmaceutical sample.

36. The method of claim 30, wherein the step of supplying an identifier for a pharmaceutical item further comprises the step of supplying an identifier for an injectable item.

37. The method of claim 29, wherein the step of supplying an identifier for an item further comprises the step of supplying the identifier as a barcode.

38. The method of claim 29, wherein the step of supplying an identifier for an item further comprises the step of supplying the identifier as a radio frequency identifier.

39. The method of claim 29, wherein the step of communication with a communications device further comprises the step of communicating with a personal digital assistant.

40. The method of claim 29, wherein the step of communicating with a communications device further comprises the step of communicating with a personal computer.

41. The method of claim 29, wherein the step of communicating with a communications device further comprises the step of communicating with a cellular telephone.

42. The method of claim 29, wherein the step of receiving an electronic signature further comprises the step of receiving an electronic signature created using a stylus.

43. The method of claim 29, wherein the step of receiving an electronic signature further comprises the step of receiving an electronic signature created using a wireless technology pen.

44. The method of claim 31, wherein the step of supplying an identifier for a patient chart further comprises the step of associating the identifier with diagnostic, clinical, and treatment data about the patient and storing it in the database.

45. The method of claim 30, wherein the step of supplying an identifier for a pharmaceutical item further comprises the step of logging any transfers of the pharmaceutical item.

46. The method of claim 30, wherein the step of managing information further comprises the step of tracking the inventory of the pharmaceutical item and providing a replenishment indicator.

47. The method of claim 29, wherein the step of managing information further comprises the step of determining whether a proposed pharmaceutical is covered by the patient'"'"'s medical insurer.

48. The method of claim 30, wherein the step of managing information further comprises the steps of locating any drug interaction and instruction information relevant to a proposed prescription and providing this drug interaction and instruction information in readable form to the patient and storing in the database the patient'"'"'s electronic signature confirming receipt of said drug interaction and instruction information.

49. The method of claim 48, wherein the step of managing information further comprises the step of automatically generating a prescription upon authorization by the health care provider and transmitting it.

50. The method of claim 34, wherein the step of managing information further comprises the step of displaying a diagnosis showing at least one primary diagnosis for a patient whenever that patient'"'"'s information is being viewed by the health care provider.

51. The method of claim 29, wherein the step of managing information further comprises the step of logging transactions to permanently record and identify designated transactions.

52. The method of claim 44, wherein the step of managing information further comprises the step of associating the identifier from the patient'"'"'s chart with stored patient data in the database.

53. The method of claim 52, wherein the step of managing information further comprises the step of collecting and displaying clinical information about the patient stored in the database, the information being indicative of the patient'"'"'s compliance with a prescribed treatment.

54. The method of claim 52, wherein the step of managing information further comprises the steps of analyzing reactions of a specified group of patients stored in the database to prescribed treatments using a network analysis program and reporting the results without divulging any patient identifying data.

55. The method of claim 52, wherein the step of managing information further comprises the step of comparing patient data stored in the database to standard response data stored in the database for prescribed treatments to determine whether the patient is responding as expected.

56. The method of claim 52, wherein the step of managing information further comprises the step of comparing data for patients having the same diagnosis but having at least two different prescribed treatments and summarizing the outcomes.

57. A machine readable medium for storing a system for managing information about pharmaceuticals, patients, and health care providers, comprising a database for storing pharmaceutical data and patient data;

communications device support, capable of supporting communications devices for reading identifiers, displaying data, and receiving electronic signatures;

a communications pathway;

a management system capable of communicating with the communications device over the communications pathway and with the database, the management system supplying an identifier to be used on a readable label attached to an item such that the identifier can be read by the communications device.